N-power Medicine

This study is not testing a new treatment. Instead, it follows about 130 adults with advanced EGFR-mutant non-small cell lung cancer who are starting standard therapy (osimertinib). Researchers will collect information on how long the cancer stays under control and how long patie…

This study is a large registry that gathers information from adult cancer patients during their routine care. Researchers will collect details on treatments, side effects, and outcomes, along with patient surveys. The goal is to create a rich dataset that helps doctors understand…

This study does not test a new treatment. Instead, it collects information from 550 people with advanced lung cancer who are receiving standard therapies. The goal is to create detailed control groups that can be used in future clinical trials, making them more accurate and effic…